Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | INSL3 |
| Upstream (Parents) |
|---|
| (<<) TWF1 → INSL3 |
| (<<) TH → INSL3 |
| (<<) CRISP2 → INSL3 |
| (<<) NPBWR2 → INSL3 |
| (<<) RGS9 → INSL3 |
| (<<) SIK2 → INSL3 |
| (<<) SPON2 → INSL3 |
| (<<) ICAM2 → INSL3 |
| Downstream (Children) |
|---|
| INSL3 → HIST2H4B///HIST4H4///HIST2H4A///HIST1H4L///HIST1H4E///HIST1H4B///HIST1H4H///HIST1H4C///HIST1H4J///HIST1H4K///HIST1H4F///HIST1H4D///HIST1H4A///HIST1H4I (>>) |
| INSL3 → NPBWR2 (>>) |
| INSL3 → GRIA1 (>>) |
| INSL3 → PSG2 (>>) |
| INSL3 → SIK2 (>>) |
| INSL3 → USP49 (>>) |
